1. Home
  2. AMRX vs CATY Comparison

AMRX vs CATY Comparison

Compare AMRX & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • CATY
  • Stock Information
  • Founded
  • AMRX 2002
  • CATY 1962
  • Country
  • AMRX United States
  • CATY United States
  • Employees
  • AMRX N/A
  • CATY N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • CATY Major Banks
  • Sector
  • AMRX Health Care
  • CATY Finance
  • Exchange
  • AMRX Nasdaq
  • CATY Nasdaq
  • Market Cap
  • AMRX 3.3B
  • CATY 3.4B
  • IPO Year
  • AMRX N/A
  • CATY N/A
  • Fundamental
  • Price
  • AMRX $10.05
  • CATY $48.55
  • Analyst Decision
  • AMRX Strong Buy
  • CATY Hold
  • Analyst Count
  • AMRX 4
  • CATY 5
  • Target Price
  • AMRX $12.00
  • CATY $50.00
  • AVG Volume (30 Days)
  • AMRX 1.7M
  • CATY 423.2K
  • Earning Date
  • AMRX 10-30-2025
  • CATY 10-21-2025
  • Dividend Yield
  • AMRX N/A
  • CATY 2.79%
  • EPS Growth
  • AMRX N/A
  • CATY N/A
  • EPS
  • AMRX 0.01
  • CATY 4.14
  • Revenue
  • AMRX $2,852,914,000.00
  • CATY $704,760,000.00
  • Revenue This Year
  • AMRX $9.52
  • CATY $17.40
  • Revenue Next Year
  • AMRX $6.31
  • CATY $6.77
  • P/E Ratio
  • AMRX $965.99
  • CATY $11.79
  • Revenue Growth
  • AMRX 9.81
  • CATY N/A
  • 52 Week Low
  • AMRX $6.69
  • CATY $36.06
  • 52 Week High
  • AMRX $10.68
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 53.42
  • CATY 50.50
  • Support Level
  • AMRX $10.35
  • CATY $47.29
  • Resistance Level
  • AMRX $10.61
  • CATY $49.76
  • Average True Range (ATR)
  • AMRX 0.28
  • CATY 0.79
  • MACD
  • AMRX 0.00
  • CATY -0.00
  • Stochastic Oscillator
  • AMRX 48.31
  • CATY 54.45

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: